Related Experiment Videos

Primary operative versus nonoperative therapy for pediatric empyema: a meta-analysis

Jeffrey R Avansino1, Bryan Goldman, Robert S Sawin

  • 1Department of Surgery, University of Washington, Box 356410, Seattle, WA 98105, USA. javansin@u.washington.edu

Pediatrics
|June 3, 2005
PubMed

Insights

Primary operative therapy for pediatric empyema significantly reduces mortality, reinterventions, and hospital stay compared to nonoperative treatment. This approach offers a lower risk of treatment failure in children with empyema.

Area of Science:

  • Pediatric Surgery
  • Thoracic Medicine
  • Infectious Diseases

Background:

  • Pediatric empyema treatment remains a subject of debate.
  • Optimal management strategies require careful consideration of outcomes.

Purpose of the Study:

  • To compare nonoperative and primary operative therapies for pediatric empyema.
  • To evaluate reported outcomes including mortality, reintervention, and length of stay.

Main Methods:

  • A systematic literature review of PubMed (1981-2004) identified studies on pediatric empyema treatment.
  • Meta-analysis was performed on studies with sufficient data for comparative outcomes.
  • Sixty-seven studies were reviewed, aggregating data from 3418 nonoperative and 363 operative cases.

Main Results:

  • Primary operative therapy showed lower in-hospital mortality (0% vs. 3.3%) and reintervention rates (2.5% vs. 23.5%).
  • Operative treatment resulted in shorter hospital stays (10.8 vs. 20.0 days), tube thoracostomy duration (4.4 vs. 10.6 days), and antibiotic therapy (12.8 vs. 21.3 days).
  • Meta-analysis indicated a pooled relative risk of failure of 0.09 for operative treatment.

Conclusions:

  • Primary operative therapy is associated with improved outcomes in pediatric empyema.
  • Shorter recovery times and reduced failure rates support operative intervention.
  • Operative management offers significant advantages over nonoperative approaches for pediatric empyema.
Abstract

Related Concept Videos

Tonsillitis II: Management01:26

Tonsillitis II: Management

This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include: